Suchergebnisse
IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?
Shares of Ironwood Pharmaceuticals IRWD have witnessed a sharp decline over the past month, primarily due to softer sales of its sole marketed product, Linzess (linaclotide), during the fourth
